| Literature DB >> 33186634 |
Yanmin Cheng1, Zhaozhao Shao2, Li Chen3, Qiaoyu Zheng4, Qiqi Zhang5, Wenjie Ding6, Meng Zhang7, Qiongfang Yu8, Dian Gao9.
Abstract
Thymocyte selection-associated high mobility group box protein (TOX), a member of the high-motility group box (HMG) protein superfamily, is an evolutionarily conserved DNA-binding protein. It functions as a transcription factor that modulates transcriptional programs by binding to DNA in a structure-dependent manner. It has been well established that TOX is required for the development of CD4+ T cells, natural killer (NK) cells and innate lymphoid cells (ILCs), as well as the autoimmunity mediated by CD8+ T cells. Recently, emerging evidence supports an essential role for TOX in the induction of T cell exhaustion in the setting of tumor or chronic viral infection by mediating transcriptional and epigenetic changes, which are cardinal hallmarks of exhausted T cells. Moreover, TOX plays a key role in the persistence of antigen-specific T cells and in the mitigation of tissue damage caused by immunopathology over the course of tumorigenesis and chronic infection. Additionally, TOX contributes to the high level of programmed cell death protein 1 (PD-1) on the cell surface by participating in the process of endocytic recycling of PD-1. In this review, we summarize the most recent information about the role of TOX in the process of T cell exhaustion, which enriches our understanding of the molecular mechanisms of CD8+ T cell exhaustion upon chronic antigen stimulation and reveals promising therapeutic targets for persisting infection and cancer.Entities:
Keywords: Checkpoint blockade; PD-1; T cell exhaustion; TOX; Thymocyte selection-associated high mobility group box protein
Mesh:
Substances:
Year: 2020 PMID: 33186634 DOI: 10.1016/j.imlet.2020.11.004
Source DB: PubMed Journal: Immunol Lett ISSN: 0165-2478 Impact factor: 3.685